News

BMJ1d
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis
Objectives To assess the efficacy and safety of abatacept, a selective T-cell costimulation modulator, in a phase III study in psoriatic arthritis (PsA). Methods This study randomised patients (1:1) ...
BMJ2d
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)
10 Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA Correspondence to Frank Buttgereit, Department of Rheumatology and Clinical ...
BMJ2d
Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use
Background The effects of fish oil (FO) in rheumatoid arthritis (RA) have not been examined in the context of contemporary treatment of early RA. This study examined the effects of high versus low ...
BMJ4d
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores
2 Rheumatology Department, Leiden University Medical Center, Leiden, The Netherlands 3 Rheumatology Department, Maastricht University Medical Center, Maastricht, The Netherlands Background The ...
BMJ4d
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
Objective To evaluate the efficacy and safety of etanercept (ETN) after 48 weeks in patients with early active non-radiographic axial spondyloarthritis (nr-axSpA). Methods Patients meeting Assessment ...
BMJ4d
How to diagnose axial spondyloarthritis early
Background: Chronic low back pain (LBP), the leading symptom of ankylosing spondylitis (AS) and undifferentiated axial spondyloarthritis (SpA), precedes the development of radiographic sacroiliitis, ...
BMJ5d
High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
2 Division of Preventive and Behavioral Medicine, University of Massachusetts School of Medicine, Worcester, Massachusetts, USA 3 Division of Clinical Immunology and Rheumatology, University of ...
BMJ6d
Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial
VU University Medical Center, Clinical Epidemiology & Biostatistics, Amsterdam, The Netherlands Lilian H D van Tuyl, VU University Medical Center, Department of Clinical Epidemiology & Biostatistics, ...
BMJ7d
Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice
OBJECTIVES To study the delay in starting disease modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA), and any changes in medical practice between 1980 and 1997. METHODS ...
BMJ9d
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis
Correspondence to Dr Adrian Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, Zurich CH-8091, Switzerland; adrian.ciurea{at}usz.ch Objectives To investigate the impact ...
BMJ9d
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel
17 Department of Gerontology & Geriatrics VUB, University Hospital, Brussels, Belgium 18 Department of Geriatric Medicine, University Hospital Ghent, Ghent, Belgium Introduction Given the safety ...